Editorial-Details (JBB)

Chandrajeet Singh

Research Scientist
Department of Biochemistry & Molecular Genetics
University of Virginia School of Medicine
United States of America

Biography

Dr. Chandrajeet Singh, Ph.D. is a Research Scientist in the Department of Surgery at the University of Virginia School of Medicine, USA. He received his Ph.D. in Life Sciences from the Central University of Gujarat, India, and subsequently completed research training at the National Agri-Food Biotechnology Institute, Jawaharlal Nehru University, and the University of Virginia. His academic and research career has focused primarily on molecular oncology, cancer biology, and translational cancer research. Dr. Singh's research has particularly focused on the molecular mechanisms underlying triple-negative breast cancer (TNBC), with an emphasis on tumor progression, metastasis, chemoresistance, immune evasion, and therapeutic targeting. His work has investigated oncogenic signaling pathways and molecular regulators including PIM1/PIM2 kinases and AXL, as well as mechanisms involving cell adhesion, integrin expression, protein glycosylation, and tumor–microenvironment interactions. He has authored and co-authored research articles, book chapters, reviews, and conference abstracts in the fields of cancer biology, molecular medicine, biotechnology, and nutritional science. He has also presented his research at national and international scientific meetings, including the American Association for Cancer Research (AACR) Annual Meeting. In addition to his research activities, Dr. Singh has supervised students in molecular biology and cell culture and serves as a peer reviewer for several international scientific journals. He is also involved in the editorial development of a book on Triple-Negative Breast Cancer: Emerging Molecular Drivers and Therapeutic Horizons.

Research Interest

Triple-negative breast cancer (TNBC); molecular oncology; cancer biology; tumor progression and metastasis; oncogenic signaling; PIM1/PIM2 and AXL pathways; chemoresistance; tumor immune evasion; cell adhesion and migration; integrin biology and glycosylation; cancer therapeutics; molecular biomarkers; translational cancer research; molecular biology; and nutrigenomics

ISSN

ISSN No: 2996-0339

Journal Information

  • Frequency: Monthly
  • Publication: Online & Print
  • Impact Factor (2024): 0.247
  • Journal Type: Open Access
No Plagiarism Badge Creative Commons CC BY License
Reviewer Icon